IVIg for TS‐HDS and FGFR ‐3 antibody–positive small‐fiber neuropathy: A fading signal for efficacy?
Muscle & Nerve · 2023
DOI: 10.1002/mus.27800 ↗Kurz gefasst
Editorial in der Zeitschrift Muscle & Nerve, 2023. Verfasst von Hans D Katzberg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Toronto General Hospital/University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Immunoglobulins, Intravenous, Small Fiber Neuropathy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
See article on pages 363–370 in this issue .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Toronto General Hospital/University Health Network, Toronto, Ontario, Canada.
ORCID-Profile: Hans D Katzberg, Carolina Barnett
Zitieren
APA
Katzberg, H. D., & Barnett, C. (2023). IVIg for TS‐HDS and FGFR ‐3 antibody–positive small‐fiber neuropathy: A fading signal for efficacy?. Muscle & Nerve. https://doi.org/10.1002/mus.27800
Vancouver
Katzberg HD, Barnett C. IVIg for TS‐HDS and FGFR ‐3 antibody–positive small‐fiber neuropathy: A fading signal for efficacy?. Muscle & Nerve. 2023. doi:10.1002/mus.27800
BibTeX
@article{Katzberg2023,
author = {Katzberg, Hans D and Barnett, Carolina},
title = {IVIg for TS‐HDS and FGFR ‐3 antibody–positive small‐fiber neuropathy: A fading signal for efficacy?},
journal = {Muscle & Nerve},
year = {2023},
doi = {10.1002/mus.27800}
}
EUVIMED